rs376566207
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_021098.3(CACNA1H):c.552G>A(p.Met184Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000273 in 1,612,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 missense
NM_021098.3 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 5.66
Publications
0 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3480633).
BP6
Variant 16-1195932-G-A is Benign according to our data. Variant chr16-1195932-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 568589.
BS2
High AC in GnomAdExome4 at 43 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.513G>A | p.Met171Ile | missense_variant | Exon 5 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.513G>A | p.Met171Ile | missense_variant | Exon 5 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.552G>A | p.Met184Ile | missense_variant | Exon 5 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711448.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.552G>A | non_coding_transcript_exon_variant | Exon 5 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000711442.1 | n.*90+273G>A | intron_variant | Intron 4 of 33 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152182Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000121 AC: 3AN: 248280 AF XY: 0.0000222 show subpopulations
GnomAD2 exomes
AF:
AC:
3
AN:
248280
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460588Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 726616 show subpopulations
GnomAD4 exome
AF:
AC:
43
AN:
1460588
Hom.:
Cov.:
32
AF XY:
AC XY:
24
AN XY:
726616
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33470
American (AMR)
AF:
AC:
0
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26122
East Asian (EAS)
AF:
AC:
0
AN:
39696
South Asian (SAS)
AF:
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
AC:
0
AN:
52580
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
42
AN:
1111642
Other (OTH)
AF:
AC:
1
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.427
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
152182
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41434
American (AMR)
AF:
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68036
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Feb 07, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Oct 13, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;.;N;N
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N
REVEL
Uncertain
Sift
Benign
T;.;T;T
Sift4G
Benign
T;.;T;T
Polyphen
B;.;B;B
Vest4
MutPred
Gain of catalytic residue at M184 (P = 0.0031);.;Gain of catalytic residue at M184 (P = 0.0031);Gain of catalytic residue at M184 (P = 0.0031);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.